Immunohistochemical and biochemical assessment of caspase-3 activation and DNA fragmentation following transient focal ischemia in the rat

In the present study, we evaluated the time-course of caspase-3 activation, and the evolution of cell death following focal cerebral ischemia produced by transient middle cerebral artery occlusion in rats. Ischemia-induced active caspase-3 immunoreactivity in the striatum but not the cortex at 3 and 6 h time points post-reperfusion. Furthermore, using a novel approach to visualize enzymatic activity, deltaC-APP, a C-terminal cleavage product of APP generated by caspase-3, was found to immunolocalize to the same areas as active caspase-3. Double-labeling studies demonstrated co-localization of these two proteins at the cellular level. Further double-labeling experiments revealed that active caspase-3 was confined to neuronal cells which were still viable and thus immunoreactive for NeuN. DNA fragmentation, assessed histologically by terminal dUTP nick-end labeling (TUNEL), was observed in a small number of cells in the striatum as early as 3 h, but only began to appear in the cortex by 6 h. DNA fragmentation was progressive, and by 24 h post-reperfusion, large portions of both the striatum and cortex showed TUNEL positive cells. However, double-labeling of active caspase-3 with TUNEL showed only minimal co-localization at all time-points. Thus, caspase-3 activation is an event that appears to occur prior to DNA fragmentation. As a confirmation of the histological TUNEL data, 24 h ischemia also induced the generation of nucleosome fragments, evidenced by cell death enzyme-linked immunosorbent assay. Using a novel ischemia-induced substrate cleavage biochemical approach, spectrin P120 fragment, a caspase-specific cleavage product of alpha II spectrin, a cytoskeletal protein, was shown to be elevated by western blotting. Brain concentrations of both nucleosomes and spectrin P120 correlate with the degree of injury previously assessed by triphenyltetrazolium chloride staining and infarct volume calculation. Together, our findings suggest a possible association between caspase-3 activation and ischemic cell death following middle cerebral artery occlusion brain injury.

[1]  R. L. Hayes,et al.  Maitotoxin Induces Calpain But Not Caspase-3 Activation and Necrotic Cell Death in Primary Septo-Hippocampal Cultures , 1999, Neurochemical Research.

[2]  G. Salvesen,et al.  Properties of the caspases. , 1998, Biochimica et biophysica acta.

[3]  R. J. Mullen,et al.  NeuN, a neuronal specific nuclear protein in vertebrates. , 1992, Development.

[4]  B. Bahr,et al.  The pathogenic activation of calpain: a marker and mediator of cellular toxicity and disease states , 2000, International journal of experimental pathology.

[5]  M. Moskowitz,et al.  Activation and Cleavage of Caspase-3 in Apoptosis Induced by Experimental Cerebral Ischemia , 1998, The Journal of Neuroscience.

[6]  M. Chopp,et al.  In situ detection of DNA fragmentation after focal cerebral ischemia in mice. , 1995, Brain Research. Molecular Brain Research.

[7]  A. Faden,et al.  Caspase pathways, neuronal apoptosis, and CNS injury. , 2000, Journal of neurotrauma.

[8]  T. Shiraishi,et al.  Visualization of DNA double strand breaks in the gerbil hippocampal CA1 following transient ischemia , 1994, Neuroscience Letters.

[9]  J. Velier,et al.  Caspase-8 and Caspase-3 Are Expressed by Different Populations of Cortical Neurons Undergoing Delayed Cell Death after Focal Stroke in the Rat , 1999, The Journal of Neuroscience.

[10]  T. Yoshimoto,et al.  Endonuclease activation following focal ischemic injury in the rat brain , 1993, Brain Research.

[11]  A. Shah,et al.  Caspase inhibitor affords neuroprotection with delayed administration in a rat model of neonatal hypoxic-ischemic brain injury. , 1998, The Journal of clinical investigation.

[12]  G. Paxinos,et al.  The Rat Brain in Stereotaxic Coordinates , 1983 .

[13]  Comparison of Caspase Activation and Subcellular Localization in HL-60 and K562 Cells Undergoing Etoposide-Induced Apoptosis , 1997 .

[14]  J. Kemp,et al.  Is caspase-3 inhibition a valid therapeutic strategy in cerebral ischemia? , 2001, Drug discovery today.

[15]  Patrick R. Griffin,et al.  Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis , 1995, Nature.

[16]  R. Talanian,et al.  Simultaneous Degradation of αII- and βII-Spectrin by Caspase 3 (CPP32) in Apoptotic Cells* , 1998, The Journal of Biological Chemistry.

[17]  William Slikker,et al.  Fluoro-Jade: a novel fluorochrome for the sensitive and reliable histochemical localization of neuronal degeneration , 1997, Brain Research.

[18]  F. Silverstein Can inhibition of apoptosis rescue ischemic brain? , 1998, The Journal of clinical investigation.

[19]  A. Buchan,et al.  A New Model of Temporary Focal Neocortical Ischemia in the Rat , 1992, Stroke.

[20]  Y. Ben-Ari,et al.  Early Endonuclease Activation following Reversible Focal Ischemia in the Rat Brain , 1995, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[21]  Keisuke Kuida,et al.  Decreased apoptosis in the brain and premature lethality in CPP32-deficient mice , 1996, Nature.

[22]  Guo-Yuan Yang,et al.  Mice Deficient in Interleukin-1 Converting Enzyme are Resistant to Neonatal Hypoxic-Ischemic Brain Damage , 1999, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[23]  R. Gill,et al.  Ultrastructural morphological changes are not characteristic of apoptotic cell death following focal cerebral ischaemia in the rat , 1996, Neuroscience Letters.

[24]  M. Moskowitz,et al.  Attenuation of Delayed Neuronal Death after Mild Focal Ischemia in Mice by Inhibition of the Caspase Family , 1998, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[25]  Y. Ben-Ari,et al.  A cautionary note on the use of the TUNEL stain to determine apoptosis , 1995, Neuroreport.

[26]  K. Abe,et al.  Temporal profile of cytochrome c and caspase-3 immunoreactivities and TUNEL staining after permanent middle cerebral artery occlusion in rats , 2000, Neurological research.

[27]  R. Simon,et al.  Induction of Caspase-3-Like Protease May Mediate Delayed Neuronal Death in the Hippocampus after Transient Cerebral Ischemia , 1998, The Journal of Neuroscience.

[28]  S. Nagata Apoptotic DNA fragmentation. , 2000, Experimental cell research.

[29]  T. Wieloch,et al.  The time-course of DNA fragmentation in the choroid plexus and the CA1 region following transient global ischemia in the rat brain. The effect of intra-ischemic hypothermia , 1999, Neuroscience.

[30]  W. Earnshaw,et al.  Nuclear changes in apoptosis. , 1995, Current opinion in cell biology.

[31]  J. Morrow,et al.  Development and characterization of antibodies specific to caspase-3-produced alpha II-spectrin 120 kDa breakdown product: marker for neuronal apoptosis , 2000, Neurochemistry International.

[32]  L. Schmued,et al.  Fluoro-Jade: Novel Fluorochromes for Detecting Toxicant-Induced Neuronal Degeneration , 2000, Toxicologic pathology.

[33]  Y. Ben-Ari,et al.  Rapid Communication: Regional Variability in DNA Fragmentation After Global Ischemia Evidenced by Combined Histological and Gel Electrophoresis Observations in the Rat Brain , 1993, Journal of neurochemistry.

[34]  G. Cole,et al.  Apoptosis in a neonatal rat model of cerebral hypoxia-ischemia. , 1998, Stroke.

[35]  I. Ferrer,et al.  Identification of necrotic cell death by the TUNEL assay in the hypoxic-ischemic neonatal rat brain , 1997, Neuroscience Letters.

[36]  N. Thornberry,et al.  A Combinatorial Approach Defines Specificities of Members of the Caspase Family and Granzyme B , 1997, The Journal of Biological Chemistry.

[37]  S. Murota,et al.  A caspase inhibitor blocks ischaemia‐induced delayed neuronal death in the gerbil , 1998, The European journal of neuroscience.

[38]  N. Thornberry,et al.  A combinatorial approach for determining protease specificities: application to interleukin-1beta converting enzyme (ICE). , 1997, Chemistry & biology.

[39]  B. Pike,et al.  Temporal relationships between de novo protein synthesis, calpain and caspase 3‐like protease activation, and DNA fragmentation during apoptosis in septo‐hippocampal cultures , 1998, Journal of neuroscience research.

[40]  David Smith,et al.  Involvement of Caspases in Proteolytic Cleavage of Alzheimer’s Amyloid-β Precursor Protein and Amyloidogenic Aβ Peptide Formation , 1999, Cell.

[41]  S. Paul,et al.  Transient Global Forebrain Ischemia Induces a Prolonged Expression of the Caspase-3 mRNA in Rat Hippocampal CA1 Pyramidal Neurons , 1998, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[42]  M. Chopp,et al.  Ultrastructural and light microscopic evidence of apoptosis after middle cerebral artery occlusion in the rat. , 1995, The American journal of pathology.

[43]  I. Ferrer,et al.  Expression of Caspases and Their Substrates in the Rat Model of Focal Cerebral Ischemia , 2000, Neurobiology of Disease.

[44]  S. Muller,et al.  An ELISA for detection of apoptosis. , 1997, Nucleic acids research.

[45]  M. Johnston,et al.  Apoptosis Has a Prolonged Role in the Neurodegeneration after Hypoxic Ischemia in the Newborn Rat , 2000, The Journal of Neuroscience.

[46]  David S. Park,et al.  Caspase 3 Deficiency Rescues Peripheral Nervous System Defect in Retinoblastoma Nullizygous Mice , 2001, The Journal of Neuroscience.